Health & Safety Industry Today
Asia-Pacific In Vitro Diagnostics Market: Competitive Dynamics & Global Outlook 2025
Addressing the most sought-after questions that occupy the minds of entrepreneurs and decision makers, the new report of "Stratview Research" on the Asia-Pacific In Vitro Diagnostics Market, answers all the important questions.
Published 29 July 2019
Getting to the bare bones of the issues and factors which are sculpturing the market, Stratview Research brings out the best actionable market intelligence for the global Asia-Pacific In Vitro Diagnostics Market.
The analysts have scrupulously studied the trend and cautiously forecasted the future market developments for 2019-2025.
The important questions the report answers are:
These questions and many more, big and small, are all discussed in the report in great detail.
Asia-Pacific In Vitro Diagnostics (IVD) Market Insights
Due to high density of population and the increase in healthcare expenditure, Asia Pacific has been in focus from the last 2 decades. The disease pattern has also changed where new technologies are being used to diagnose more cases. In a survey conducted 6 years back in APAC countries, regions such as China, Hong Kong, and Taiwan (North Asia), and Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam (Southeast Asia). Showed a growing trend towards COPD. The overall estimated prevalence of COPD was 6.2%, ranging from 4.5% in Indonesia to 9.5% in Taiwan. Physician diagnosis was higher in North Asia (72–93%) than in Southeast Asia (19–60%), with the exception of Vietnam (92%). Studies estimate that 62 per cent of all overweight people reside in a developing country, with Asia and the Pacific as the home to the largest absolute number of overweight and obese people at about 1 billion people i.e. 2 in 5 adults in Asia Pacific. UNAIDS reported that in 2017, there were an estimated 280,000 new HIV infections in the Asia-Pacific, bringing the total number living with HIV/AIDS in the region to 5.2 million. In 2017, approximately 170,000 people died from AIDS-related illnesses in the region, a 39% decline in deaths since 2010, but in some countries AIDS-related deaths have increased. Singapore reported cancer (29.1%) as the leading cause of death in 2017, followed by heart and hypertensive diseases at 23.8% and pneumonia at 20.1%. With increase in detection of disease, increases the need of advanced diagnostics.
Asia-Pacific In Vitro Diagnostics Market Segmentation
APAC
Get a free sample of the report:
https://www.stratviewresearch.com/Request-Sample/457/in-vitro-diagnostic-ivd-market-in-asia-pacific.html
Market Segments
AI is making inroads in IVD in APAC. In recent times, machine learning software for primary diagnosis and clinical research are being developed all over APAC. One thing is certain that pathologists will see AI applied to their work in the next few years. A growing body of research shows computer algorithms may soon outperform human pathologists in both accuracy and speed. Major markets such as China, Japan, Singapore and Australia are expected to be the early adopters of such technology.
The market is divided in terms of consumption and manufacturing sectors. While Indonesia, China, India, Japan, Korea and Australia are major manufacturing markets for APAC and West, the remaining regions are consumption market which purchases the equipment from the IVD manufacturers. The report from Stratview consider both sides of the industry (consumption and manufacturing) and focuses on the import/export destinations of the major market, technology, disease pattern, usage of products & Services and the end user perspective for the next 7 years i.e. till 2025.
China, India, Japan and Australia remains the most attractive markets in APAC. Apart from these, countries such as Philippines, Malaysia, and Singapore are gaining focus, as many of these regions have recorded high number of cases of diabetes, heart related issues, obesity, smoking related respiratory issues lately. Considering the growth of economy in these regions, demand for IVD and spending power of people and coverage by the Government, these markets will attract more players in the future.
Point of care testing is one of the most attractive segments in APAC. Australia, Indonesia are few of the advanced markets where adoption rates are higher compared to others. Besides POC, Molecular diagnostic is also gaining focus and would be one of the fast growing segments in APAC. Overall this report helps the reader understand the domestic versus global competition, import/export market, technology and other aspects which can help them strategize their position in Asia Pacific.
Click Here for Other Reports from Stratview Research in the Advanced materials Industry:
https://www.stratviewresearch.com/market-reports/Healthcare-and-Life-Sciences.html
The analysts have scrupulously studied the trend and cautiously forecasted the future market developments for 2019-2025.
The important questions the report answers are:
- What will be the market growth rate in the near future?
- What are the major developments in the market wrt regulations, acquisitions and innovations?
- What are the growth drivers as well as the constraints?
- What are the regional growth hotspots?
- What are the segmental growth forecasts?
These questions and many more, big and small, are all discussed in the report in great detail.
Asia-Pacific In Vitro Diagnostics (IVD) Market Insights
Due to high density of population and the increase in healthcare expenditure, Asia Pacific has been in focus from the last 2 decades. The disease pattern has also changed where new technologies are being used to diagnose more cases. In a survey conducted 6 years back in APAC countries, regions such as China, Hong Kong, and Taiwan (North Asia), and Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam (Southeast Asia). Showed a growing trend towards COPD. The overall estimated prevalence of COPD was 6.2%, ranging from 4.5% in Indonesia to 9.5% in Taiwan. Physician diagnosis was higher in North Asia (72–93%) than in Southeast Asia (19–60%), with the exception of Vietnam (92%). Studies estimate that 62 per cent of all overweight people reside in a developing country, with Asia and the Pacific as the home to the largest absolute number of overweight and obese people at about 1 billion people i.e. 2 in 5 adults in Asia Pacific. UNAIDS reported that in 2017, there were an estimated 280,000 new HIV infections in the Asia-Pacific, bringing the total number living with HIV/AIDS in the region to 5.2 million. In 2017, approximately 170,000 people died from AIDS-related illnesses in the region, a 39% decline in deaths since 2010, but in some countries AIDS-related deaths have increased. Singapore reported cancer (29.1%) as the leading cause of death in 2017, followed by heart and hypertensive diseases at 23.8% and pneumonia at 20.1%. With increase in detection of disease, increases the need of advanced diagnostics.
Asia-Pacific In Vitro Diagnostics Market Segmentation
APAC
- By Products & Services (Equipment, Reagents, Services, etc)
- By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
- By Therapeutic Area (Infectious Diseases, Lifestyle Disease, Neurology, Oncology, etc)
- By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
- By Domestic Versus Global Competition
- By Key Export/Import Destinations
- By Products & Services (Equipment, Reagents, Services, etc)
- By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
- By Therapeutic Area (Infectious Diseases, Lifestyle Disease, Neurology, Oncology, etc)
- By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
- By Domestic Versus Global Competition
- By Key Export/Import Destinations
- By Products & Services (Equipment, Reagents, Services, etc)
- By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
- By Therapeutic Area (Infectious Diseases, Lifestyle Disease, Neurology, Oncology, etc)
- By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
- By Domestic Versus Global Competition
- By Key Export/Import Destinations
- By Products & Services (Equipment, Reagents, Services, etc)
- By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
- By Therapeutic Area (Infectious Diseases, Lifestyle Disease, Neurology, Oncology, etc)
- By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
- By Domestic Versus Global Competition
- By Key Export/Import Destinations
Get a free sample of the report:
https://www.stratviewresearch.com/Request-Sample/457/in-vitro-diagnostic-ivd-market-in-asia-pacific.html
Market Segments
AI is making inroads in IVD in APAC. In recent times, machine learning software for primary diagnosis and clinical research are being developed all over APAC. One thing is certain that pathologists will see AI applied to their work in the next few years. A growing body of research shows computer algorithms may soon outperform human pathologists in both accuracy and speed. Major markets such as China, Japan, Singapore and Australia are expected to be the early adopters of such technology.
The market is divided in terms of consumption and manufacturing sectors. While Indonesia, China, India, Japan, Korea and Australia are major manufacturing markets for APAC and West, the remaining regions are consumption market which purchases the equipment from the IVD manufacturers. The report from Stratview consider both sides of the industry (consumption and manufacturing) and focuses on the import/export destinations of the major market, technology, disease pattern, usage of products & Services and the end user perspective for the next 7 years i.e. till 2025.
China, India, Japan and Australia remains the most attractive markets in APAC. Apart from these, countries such as Philippines, Malaysia, and Singapore are gaining focus, as many of these regions have recorded high number of cases of diabetes, heart related issues, obesity, smoking related respiratory issues lately. Considering the growth of economy in these regions, demand for IVD and spending power of people and coverage by the Government, these markets will attract more players in the future.
Point of care testing is one of the most attractive segments in APAC. Australia, Indonesia are few of the advanced markets where adoption rates are higher compared to others. Besides POC, Molecular diagnostic is also gaining focus and would be one of the fast growing segments in APAC. Overall this report helps the reader understand the domestic versus global competition, import/export market, technology and other aspects which can help them strategize their position in Asia Pacific.
Click Here for Other Reports from Stratview Research in the Advanced materials Industry:
https://www.stratviewresearch.com/market-reports/Healthcare-and-Life-Sciences.html
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
